C. Janneke van der Woude

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

David C. Wilson, Judy H. Cho, C. Gieger, 2018, Nature Communications.

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients

E. Kuipers, C. Janneke van der Woude, C. de Haar, 2012, Alimentary pharmacology & therapeutics.

Assessing fatigue and sleep in chronic diseases using physiological signals from wearables: A pilot study

R. Reilmann, M. van Gils, I. Pandis, 2022, Frontiers in Physiology.

Defective ATG16L1-mediated removal of IRE1α drives Crohn’s disease–like ileitis

M. Parkes, S. Targan, A. Kaser, 2017, The Journal of experimental medicine.

Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.

Jingyuan Fu, A. Zhernakova, C. Wijmenga, 2021, Gastroenterology.

Wnt pathway-related gene expression during malignant progression in ulcerative colitis.

E. Kuipers, R. Fodde, P. Franken, 2007, Acta histochemica.

Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases.

D. Plichta, H. Vlamakis, R. Xavier, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Disappointing Durable Remission Rates in Complex Crohn's Disease Fistula

I. Molendijk, C. Janneke van der Woude, A. van der Meulen-de Jong, 2014, Inflammatory bowel diseases.

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-Analysis of 1317 Patients From 14 Studies.

A. Amiot, C. Lees, J. Gisbert, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn’s and Colitis Organization

S. Vavricka, L. Peyrin-Biroulet, S. Danese, 2020, Gastroenterology.

Increased Suppressor of Cytokine Signaling-3 Expression Predicts Mucosal Relapse in Ulcerative Colitis

E. Kuipers, M. Peppelenbosch, K. Biermann, 2013, Inflammatory bowel diseases.

S1035 Analysis of Baseline Characteristics Associated With Clinical Response to Ustekinumab IV Re-Induction Strategy in Patients With Crohn’s Disease in the POWER Trial

B. Feagan, C. Janneke van der Woude, B. Salzberg, 2023, American Journal of Gastroenterology.